Semaglutide

Semaglutide is a synthetic peptide and glucagon-like peptide-1 (GLP-1) receptor agonist used in scientific research involving metabolic signalling, glucose regulation and related biological pathways.

FDA-approved prescription medicines containing semaglutide include specific Ozempic, Wegovy and Rybelsus formulations. However, approval of these branded medicines does not mean that every product containing semaglutide is FDA-approved.

Product Features

• Supplied in a securely sealed and clearly labelled vial
• Suitable for controlled laboratory and analytical research
• Supports research involving GLP-1 receptor activity
• Intended for handling by qualified research professionals
• Available for identification, testing and laboratory investigation

Storage

Store securely according to the conditions stated on the product label or accompanying documentation. Protect the product from excessive heat, moisture and direct sunlight.

Important Notice

This product is offered strictly for laboratory research purposes. It is not an approved prescription medicine and must not be marketed as equivalent to Ozempic, Wegovy, Rybelsus or another FDA-approved product. The FDA has warned consumers about unapproved semaglutide and other GLP-1 products because their safety, quality and effectiveness have not undergone the agency’s approval review.

For research use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure or prevent any disease.